menu

Key Pathways to Reducing Recurrent Hypoglycemia Risk in Patients with Insulin-Treated T2D

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Key Pathways to Reducing Recurrent Hypoglycemia Risk in Patients with Insulin-Treated T2D

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Rozalina G. McCoy, an endocrinologist, primary care physician, and a National Institutes of Health-funded health services researcher examines hypoglycemia risk in insulin-treated type 2 diabetic patients and explores strategies to reduce their risk of recurrent hypoglycemia. 

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Rozalina G. McCoy, an endocrinologist, primary care physician, and a National Institutes of Health-funded health services researcher examines hypoglycemia risk in insulin-treated type 2 diabetic patients and explores strategies to reduce their risk of recurrent hypoglycemia. 

Facebook Comments

Schedule19 Oct 2021